Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial therapy and the neonate

S J Yaffe

    Obstetrics and Gynecology
    |November 1, 1981
    PubMed
    Summary

    Neonates face higher infection risks due to immature immune systems. Dosing antibiotics like penicillins and aminoglycosides requires careful consideration of age-related metabolic and absorption changes in newborns.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Commentary: Long-term cognitive effects of drugs used during labor.

    The Western journal of medicine·2008
    Same author

    Why do we need a new journal in paediatric pharmacology?

    Paediatric drugs·2000
    Same author

    Workshop summary: nutrition of the extremely low birth weight infant.

    Pediatrics·1999
    Same author

    Workshop summary: fetal growth: its regulation and disorders.

    Pediatrics·1997
    Same author

    Summary of workshop: early discharge and neonatal hyperbilirubinemia.

    Pediatrics·1995
    Same author

    Neonatal bilirubin workshop.

    Pediatrics·1994

    Area of Science:

    • Neonatal pharmacology
    • Pediatric infectious diseases
    • Pharmacokinetics in neonates

    Background:

    • Newborns possess underdeveloped immune systems, increasing susceptibility to bacterial infections.
    • Altered infection presentation in neonates can delay diagnosis.
    • Immature metabolic and physiological functions in newborns complicate antimicrobial therapy.

    Purpose of the Study:

    • To present pharmacokinetic data for key antibiotics in neonates and infants.
    • To provide age-specific dosing information for neonatal antimicrobial therapy.
    • To address challenges in antibiotic administration due to altered drug metabolism and absorption in newborns.

    Main Methods:

    • Pharmacokinetic data collection in neonates and infants.
    • Analysis of drug absorption, distribution, metabolism, and excretion (ADME) in different age groups.
    • Dose determination based on gestational and chronological age.

    Main Results:

    • Established pharmacokinetic profiles for penicillins, cephalosporins, aminoglycosides, and chloramphenicol.
    • Demonstrated age-dependent variations in drug half-lives and absorption rates.
    • Highlighted the necessity of adjusted dosing regimens for neonates compared to adults.

    Conclusions:

    • Antibiotic dosing in neonates requires careful consideration of developmental changes.
    • Pharmacokinetic data are crucial for optimizing antimicrobial therapy in vulnerable infant populations.
    • Standard adult dosing is inappropriate for neonatal and infant populations.

    Related Experiment Videos